Co-Leaders:
Lorraine Gudas and Douglas Scherr
As a key program in the Weill Cornell Medicine (WCM) SPORE in Prostate Cancer (PCa), the Career Enhancement Program (CEP) aims to educate and mentor physician investigators and scientists in the conduct of PCa translational research. The CEP acknowledges that to achieve the foremost goal of impacting patient-oriented research is critical to engage new researchers in our programs.
Both co-leaders have extensive experience in mentoring at every academic level and significant past and current involvement in critical cancer-related organizations.
Specific Aims:
AIM 1. Recruit, mentor, and advance the careers of junior faculty committed to translational research in PCA
AIM 2. Encourage select, experienced, and established midlevel and senior-level researchers to focus their research efforts on PCa
Nicholas Brady, PhD
Targeting Drivers of Tumor Heterogeneity to Block the Progression to Neuroendocrine Prostate Cancer
Giuseppe Galletti, MD, PhD
Development of CTC-based molecular biomarkers of clinical response to PSMA-targeted radionuclide therapies
Ariel Marscicano, MD
Developing a translational platform for therapeutic delivery of image-guided prostate stereotactic body radiotherapy (SBRT) in orthotopic prostate cancer models
2020: Himanshu Nagar, MD
2019: Jan Krumsiek, PhD
2019: Francesca Khani, MD
2018: Dawid Nowak, PhD
